Enriching the therapeutic armamentarium for IBD - Université de Lorraine Access content directly
Journal Articles Nature reviews. Gastroenterology & hepatology Year : 2014

Enriching the therapeutic armamentarium for IBD

Abstract

In 2013, several new IBD drugs, including golimumab and vedolizumab, have been approved or completed successful programmes, showing efficacy in both Crohn’s disease and ulcerative colitis. In addition, classic IBD drugs have been formulated for colonic delivery, such as budesonide MMX®, which was recently approved for mild-to-moderate ulcerative colitis.
No file

Dates and versions

hal-01688810 , version 1 (19-01-2018)

Identifiers

Cite

Silvio Danese, Laurent Peyrin-Biroulet. Enriching the therapeutic armamentarium for IBD. Nature reviews. Gastroenterology & hepatology, 2014, 11 (2), pp.84 - 86. ⟨10.1038/nrgastro.2013.246⟩. ⟨hal-01688810⟩
11 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More